These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 3120587)

  • 21. Effects of fenofibrate on high and low density lipoprotein metabolism in heterozygous familial hypercholesterolemia.
    Malmendier CL; Delcroix C
    Atherosclerosis; 1985 May; 55(2):161-9. PubMed ID: 3924068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function.
    Kempen HJ; van Gent CM; Buytenhek R; Buis B
    J Lab Clin Med; 1987 Jan; 109(1):19-26. PubMed ID: 3098880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of clonidine hydrochloride versus atenolol monotherapy on serum lipids, lipid subfractions, and apolipoproteins in mild hypertension.
    Houston MC; Burger C; Hays JT; Nadeau J; Swift L; Bradley CA; Olafsson L
    Am Heart J; 1990 Jul; 120(1):172-9. PubMed ID: 2193493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multicenter comparison of the effects of simvastatin and fenofibrate therapy in severe primary hypercholesterolemia, with particular emphasis on lipoproteins defined by their apolipoprotein composition.
    Bard JM; Parra HJ; Camare R; Luc G; Ziegler O; Dachet C; Bruckert E; Douste-Blazy P; Drouin P; Jacotot B
    Metabolism; 1992 May; 41(5):498-503. PubMed ID: 1588829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipoprotein and apolipoprotein levels in angiographically defined coronary atherosclerosis.
    Schmidt SB; Wasserman AG; Muesing RA; Schlesselman SE; Larosa JC; Ross AM
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1459-62. PubMed ID: 3923814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of simvastatin, fenofibrate and/or ezetimibe on correlation of low-density lipoprotein and nonhigh-density lipoprotein cholesterol with apolipoprotein B in mixed dyslipidemic patients.
    Farnier M; Taggart W; Dong Q; Lin J; Shah A; Brudi P
    J Clin Lipidol; 2011; 5(3):179-187. PubMed ID: 21600523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-dose colestipol plus fenofibrate: effects on plasma lipoproteins, lecithin:cholesterol acyltransferase, and postheparin lipases in familial hypercholesterolemia.
    Weisweiler P
    Metabolism; 1989 Mar; 38(3):271-4. PubMed ID: 2918846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of micronized fenofibrate on plasma lipoprotein levels and hemostatic parameters of hypertriglyceridemic patients with low levels of high-density lipoprotein cholesterol in the fed and fasted state.
    Genest J; Nguyen NH; Theroux P; Davignon J; Cohn JS
    J Cardiovasc Pharmacol; 2000 Jan; 35(1):164-72. PubMed ID: 10630748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
    Saku K; Sasaki J; Arakawa K
    Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness and tolerability of a new lipid-altering agent, gemcabene, in patients with low levels of high-density lipoprotein cholesterol.
    Bays HE; McKenney JM; Dujovne CA; Schrott HG; Zema MJ; Nyberg J; MacDougall DE;
    Am J Cardiol; 2003 Sep; 92(5):538-43. PubMed ID: 12943873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.
    Stampfer MJ; Sacks FM; Salvini S; Willett WC; Hennekens CH
    N Engl J Med; 1991 Aug; 325(6):373-81. PubMed ID: 2062328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison between simvastatin and bezafibrate in effect on plasma lipoproteins and apolipoproteins in primary hypercholesterolaemia.
    Schulzeck P; Bojanovski M; Jochim A; Canzler H; Bojanovski D
    Lancet; 1988 Mar; 1(8586):611-3. PubMed ID: 2894548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The levels of lipids, lipoproteins and apolipoproteins in healthy people in the central region of the Black Sea.
    Adam B; Talu C; Bedir A; Alvur M; Sağkan O
    Jpn Heart J; 1999 Jul; 40(4):427-34. PubMed ID: 10611907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein and lipid composition of plasma lipoproteins in neonates during the first month of life.
    van Biervliet JP; Rosseneu M; Bury J; Caster H; Stul MS; Lamote R
    Pediatr Res; 1986 Apr; 20(4):324-8. PubMed ID: 3085061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies of lipids, lipoproteins, and apolipoproteins in Menkes' disease.
    Blackett PR; Lee DM; Donaldson DL; Fesmire JD; Chan WY; Holcombe JH; Rennert OM
    Pediatr Res; 1984 Sep; 18(9):864-70. PubMed ID: 6483510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension.
    Hunt SC; Wu LL; Hopkins PN; Stults BM; Kuida H; Ramirez ME; Lalouel JM; Williams RR
    Arteriosclerosis; 1989; 9(3):335-44. PubMed ID: 2497719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum lipids, lipoproteins and apolipoproteins in pregnant non-diabetic patients.
    Mazurkiewicz JC; Watts GF; Warburton FG; Slavin BM; Lowy C; Koukkou E
    J Clin Pathol; 1994 Aug; 47(8):728-31. PubMed ID: 7962626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in the distribution and composition of high-density lipoproteins in primary hypothyroidism.
    Muls E; Rosseneu M; Lamberigts G; De Moor P
    Metabolism; 1985 Apr; 34(4):345-53. PubMed ID: 3920475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of bezafibrate on plasma lipids, lipoproteins, apolipoproteins AI, AII and B and LCAT activity in hyperlipidemic, non-insulin-dependent diabetics.
    Prager R; Schernthaner G; Kostner GM; Mühlhauser I; Zechner R; Dorda W
    Atherosclerosis; 1982 Jun; 43(2-3):321-7. PubMed ID: 6810904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of fenofibrate on plasma lipoprotein composition and kinetics in patients with complete hepatic lipase deficiency.
    Ruel IL; Lamarche B; Mauger JF; Badellino KO; Cohn JS; Marcil M; Couture P
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2600-7. PubMed ID: 16224048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.